Breakthrough Business Models

Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary

AvInstitute of Medicine,Board on Health Sciences Policy

Häftad, Engelska, 2009

Del i serien Clinical Trial Data Sharing

728 kr

Beställningsvara. Skickas inom 3-6 vardagar. Fri frakt över 249 kr.

Beskrivning

The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and neglected diseases are unable to rely on such returns. On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases.

Produktinformation

Utforska kategorier

Innehållsförteckning

Hoppa över listan

Mer från samma författare

Bereavement

Institute of Medicine, Committee for the Study of Health Consequences of the Stress of Bereavement

Häftad, 1984

1 999 kr

New Vaccine Development

Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health

Häftad, 1986

1 929 kr

Physician Staffing for the VA

Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb

Häftad, 1991

1 257 kr

Hoppa över listan

Mer från samma serie

Challenges for the FDA

Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development

Häftad, 2007

621 kr

Sharing Clinical Research Data

Institute of Medicine, Board on Health Care Services, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, National Cancer Policy Forum, Forum on Neuroscience and Nervous System Disorders, and Translation Forum on Drug Discovery, Development, Steve Olson, Autumn Downey

Häftad, 2013

385 kr

Envisioning a Transformed Clinical Trials Enterprise for 2030

and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Carolyn Shore, Amanda Wagner Gee, Theresa Wizemann

Häftad, 2022

279 kr

Sharing Clinical Trial Data

Institute of Medicine, Board on Health Sciences Policy, Committee on Strategies for Responsible Sharing of Clinical Trial Data

Häftad, 2015

590 kr

Hoppa över listan

Du kanske också är intresserad av

Envisioning a Transformed Clinical Trials Enterprise for 2030

and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Carolyn Shore, Amanda Wagner Gee, Theresa Wizemann

Häftad, 2022

279 kr

Deriving Drug Discovery Value from Large-Scale Genetic Bioresources

and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Roundtable on Genomics and Precision Health, Sarah H. Beachy, Steve Olson, Amanda Wagner Gee, Siobhan Addie

Häftad, 2016

408 kr

Sharing Clinical Trial Data

Institute of Medicine, Board on Health Sciences Policy, Committee on Strategies for Responsible Sharing of Clinical Trial Data

Häftad, 2015

590 kr

Ovarian Cancers

and Medicine National Academies of Sciences, Engineering, Institute of Medicine, Board on Health Care Services, Committee on the State of the Science in Ovarian Cancer Research

Häftad, 2016

679 kr

Biomarker Tests for Molecularly Targeted Therapies

and Medicine National Academies of Sciences, Engineering, Institute of Medicine, Board on Health Care Services, Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies, Harold L. Moses, Jonathan K. Phillips, Laurene A. Graig

Häftad, 2016

562 kr

Challenges for the FDA

Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development

Häftad, 2007

621 kr